Scintigraphic evaluation of small intestinal transit in the streptozotocin induced diabetic rats

Hippokratia

Volumn 15, Issue 3, 2011, Pages 262-264

  Durmus Altun, G ^a   Vatansever, U ^a   Arzu Vardar, S ^a   Altaner, S ^a   Dirlik, B ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

99mTc mebrofenin; Diabetes mellitus; Scintigraphy; Small intestine; Streptozotocin

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GASTROINTESTINAL TRACT SCINTISCANNING; GASTROINTESTINAL TRANSIT; INTESTINE TRANSIT TIME; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; WISTAR ALBINO GLAXO RAT;

EID: 79959821929     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med. 2002; 113:449-455.
2. Chitkara DK, Delgado-Aros S, Bredenoord AJ, Cremonini F, El-Youssef M, Freese D, et al. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr. 2003; 143:609-613.
3. Ar'Rajab A, Ahren B. Long-term diabetogenic effect of streptozotocin in rats. Pancreas 1993; 8:50-57.
4. Eriksson UJ, Borg LA, Forsberg H, Styrud J. Diabetic embryopathy. Studies with animal and in vitro models. Diabetes. 1991;40 Suppl 2:94-98.
5. Broccardo M, Guerrini R, Petrella C, Improta G. Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats. Peptides. 2004; 25:1013-1020.
6. Chitme HR, Ghobadi R, Chandra M, Kaushik S. Studies on antidiarrhoeal activity of Calotropis gigantea R. Br. in experimental animals. J Pharm Pharm Sci. 2004; 7:70-75.
7. Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, et al. Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J Surg Res. 2004;118:53-57.
8. Tanabe Y, Calland JF, Schirmer BD. Effects of peritoneal injury and endotoxin on myoelectric ctivity and transit. J Surg Res. 2004; 116:330-336.
9. Gryback P, Jacobsson H, Blomquist L, Schnell PO, Hellstrom PM. Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values. Eur J Nucl Med Mol Imaging. 2002; 29:39-45.
10. Harvey E, Loberg M, Ryan J, Sikorski S, Faith W, Cooper M. Hepatic clearance mechanism of Tc-99m-HIDA and its effect on quantitation of hepatobiliary function. J Nucl Med. 1979; 20:310-313.
11. Wilen T, Gustavsson S, Jung B. Study of small bowel transport pattern in fasted, conscious rats with an intact gastrointestinal tract. A methodological study with bile-excreted 99Tcm-Solco-HIDA. Eur Surg Res. 1980; 12:283-293.
12. Sahu A, Sninsky CA, Kalra PS, Kalra SP. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology. 1990; 126:192-198.
13. Ettarh RR, Carr KE. A morphological study of the enteric mucosal epithelium in the streptozotocin-diabetic mouse. Life Sci. 1997; 61:1851-1858.
14. Sanchez SS, Genta SB, Aybar MJ, Honore SM, Villecco EI, Sanchez Riera AN. Changes in the expression of small intestine extracellular matrix proteins in streptozotocin-induced diabetic rats. Cell Biol Int. 2000; 24:881-888.
15. El-Salhy M. Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. Acta Diabetol. 2001; 38:139-144.
16. Zhao J, Liao D, Yang J, Gregersen H. Viscoelastic behavior of small intestine in streptozotocin-induced diabetic rats. Dig Dis Sci. 2003;48:2271-7.
17. Smith RB, Coupal J, DeLand FH, Triplett JW. Pharmacokinetics of hepatobiliary imaging agents in rats: concise communication. J Nucl Med. 1979; 20:45-49.
18. Zivanovic MA, Taylor DM, McCready VR, Meller ST. The stability and distribution of Tc-HIDA in vivo and in vitro. Eur J Nucl Med. 1979; 4:369-373.
19. Falchuk KR, Conlin D. The intestinal and liver complications of diabetes mellitus. Adv Intern Med. 1993; 38:269-286.
20. Iber FL, Parveen S, Vandrunen M, Sood KB, Reza F, Serlovsky R, et al. Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci. 1993; 38:45-50.
21. Oya M, Hosokawa M, Tsukada H, Fukuda K, Nakamura H, Tsukiyama K, et al. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats. Diabetes Res Clin Pract. 2003;62:69-77.
22. Lingenfelser T, Sun W, Hebbard GS, Dent J, Horowitz M. Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia. Am J Physiol. 1999; 276: 711-718.
23. Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, et al. Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism. 2001; 50:259-264.